Mitsubishi UFJ Asset Management’s CureVac CVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-79,962
Closed -$235K 1595
2024
Q3
$235K Sell
79,962
-7,552
-9% -$24.9K ﹤0.01% 943
2024
Q2
$298K Buy
87,514
+45,324
+107% +$148K ﹤0.01% 918
2024
Q1
$128K Sell
42,190
-1,932
-4% -$6.78K ﹤0.01% 1003
2023
Q4
$184K Buy
44,122
+13,687
+45% +$74.2K ﹤0.01% 1030
2023
Q3
$208K Buy
30,435
+1,635
+6% +$14.4K ﹤0.01% 1019
2023
Q2
$300K Sell
28,800
-4,025
-12% -$36K ﹤0.01% 987
2023
Q1
$229K Buy
32,825
+2,024
+7% +$17.6K ﹤0.01% 1013
2022
Q4
$197K Buy
30,801
+18,689
+154% +$138K ﹤0.01% 1019
2022
Q3
$95K Sell
12,112
-39
-0.3% -$455 ﹤0.01% 1102
2022
Q2
$165K Buy
12,151
+4,263
+54% +$70.5K ﹤0.01% 1060
2022
Q1
$155K Buy
7,888
+886
+13% +$17.7K ﹤0.01% 1091
2021
Q4
$247K Buy
7,002
+4,335
+163% +$174K ﹤0.01% 1048
2021
Q3
$146K Hold
2,667
﹤0.01% 1091
2021
Q2
$196K Buy
+2,667
New +$267K ﹤0.01% 1090

Other funds holding CVAC

Mitsubishi UFJ Asset Management's CVAC Position: Q4 2024 in Review

Mitsubishi UFJ Asset Management sold out of CureVac (CVAC) in Q4 2024, closing a stake of 79,962 shares — an estimated $235K sold.

Mitsubishi UFJ Asset Management first reported a position in CVAC in Q2 2021 and held it in 14 quarters. The position peaked at $300K in Q2 2023. 75 funds tracked by Wall St. Rank hold CVAC as of Q4 2024.

  • Mitsubishi UFJ Asset Management reported no remaining CureVac position as of Q4 2024 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management sold 79,962 CureVac shares in Q4 2024, an estimated $235K.
  • Mitsubishi UFJ Asset Management first reported a position in CureVac in Q2 2021 and held it in 14 quarters.
  • Mitsubishi UFJ Asset Management's CureVac position peaked at $300K in Q2 2023.
  • 75 funds tracked by Wall St. Rank held CureVac as of Q4 2024.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2024, filed 12 Feb 2025.